According to the new market research report "
Flow
Cytometry Market by
Technology (Cell-based, Bead-based), Product (Analyzer, Sorter, Reagents,
Consumables, Software), End user (Academia, Research Labs, Hospitals, Clinical
Laboratories, Pharma-Biotech Cos), Application - Global Forecasts to 2025",
published by MarketsandMarkets™, the Flow Cytometry Market is projected to
reach USD 6.4 billion by 2025 from USD 4.0 billion in 2019, at a CAGR of 8.3%.
Browse in-depth TOC on "Flow
Cytometry Market"
204 – Tables
40 – Figures
248 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584
The major factors driving the growth of the Flow
Cytometry Market are the technological advancements in flow cytometers,
increasing adoption of flow cytometry techniques in research activities &
clinical trials, the growing focus on immunology and immuno-oncology research,
increasing incorporation of AI platforms in flow cytometry workflows &
advancements in flow cytometry software, high incidence and prevalence of
HIV-AIDS & cancer, and availability of novel application-specific flow
cytometry products.
The bead-based flow cytometry segment is expected to
grow at the highest CAGR during the forecast period
On the basis of technology, the global market is
segmented into cell-based and bead-based flow cytometry. The bead-based flow
cytometry segment is estimated to witness the highest growth during the
forecast period. This technology offers various procedural advantages over
other cell-based assays, such as the capacity to detect multiple analytes (also
known as multiplexing), high reproducibility, stability, and speed.
Reagents and consumables are expected to hold the
largest share of the market in 2019
The market is segmented on the basis of products and
services into reagents and consumables, instruments, services, software, and
accessories. The reagents and consumables segment is expected to command the
largest share of the global market in 2019. Factors such as the development and
commercialization of high-quality application-specific reagents and assays and
the continuous requirement of flow cytometry reagents by end users (due to the
increasing number of flow cytometry-based research activities) are expected to
drive the growth of the reagents and consumables market in the coming years.
Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65374584
North
America is expected to dominate the Flow Cytometry
Market in 2019
Geographically, the market is segmented into North America, Europe,
the Asia Pacific, Latin America,
and the Middle East & Africa. North America is
expected to account for the largest share of the global market in 2019. The
favorable business environment, continuously growing number of research
activities, the rising number of drug discovery initiatives by US-based
pharmaceutical & biotechnology companies, and the strong presence of key
players are factors propelling the growth of the North American flow cytometry
industry.
The major players operating in the Flow Cytometry
Market are Becton, Dickinson and Company (US), Beckman Coulter,
Inc. (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany),
Sysmex Partec GmbH (Germany),
Luminex Corporation (US), Miltenyi Biotec GmbH (Germany),
Bio-Rad Laboratories, Inc. (US), Sony Biotechnology, Inc. (US), Agilent
Technologies, Inc. (US), bioMérieux S.A. (France),
Enzo Life Sciences, Inc. (US), Stratedigm, Inc. (US), Cytonome/ST LLC (US),
Cytek Biosciences (US), and Apogee Flow Systems Ltd. (UK).
Browse Related Reports:
Cell Analysis Market by
Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)],
Process (Cell Viability, Cell Proliferation, Signal Transduction), End User
(Pharma, Research, Biotechnology Companies) - Global Forecast to 2024
No comments:
Post a Comment